FDGKX
Price
$40.73
Change
+$0.34 (+0.84%)
Updated
Sep 4 closing price
Net Assets
9.79B
VIVIX
Price
$71.19
Change
-$0.23 (-0.32%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

FDGKX vs VIVIX

Header iconFDGKX vs VIVIX Comparison
Open Charts FDGKX vs VIVIXBanner chart's image
Fidelity Dividend Growth K
Price$40.73
Change+$0.34 (+0.84%)
VolumeN/A
Net Assets9.79B
Vanguard Value Index I
Price$71.19
Change-$0.23 (-0.32%)
VolumeN/A
Net Assets202.84B
FDGKX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FDGKX vs. VIVIX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDGKX is a StrongBuy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 203B vs. FDGKX (9.79B). VIVIX pays higher dividends than FDGKX: VIVIX (2.11) vs FDGKX (0.78). FDGKX was incepted earlier than VIVIX: FDGKX (17 years) vs VIVIX (27 years). FDGKX (0.70) is less costly to investors than VIVIX (0.04). FDGKX is a more actively managed with annual turnover of: 70.00 vs. VIVIX (9.00). FDGKX has a lower initial minimum investment than VIVIX: FDGKX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.74 vs. FDGKX (5.04). VIVIX return over 5 years is better than : 70.16 vs. FDGKX (59.17).
FDGKXVIVIXFDGKX / VIVIX
Total Expense Ratio0.700.041,750%
Annual Report Gross Expense Ratio0.700.041,750%
Fund Existence17 years27 years-
Gain YTD6.7727.86686%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.79B203B5%
Annual Yield % from dividends0.782.1137%
Returns for 1 year5.047.7465%
Returns for 3 years34.0736.6193%
Returns for 5 years59.1770.1684%
Returns for 10 years36.17131.6127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XRTX0.820.01
+1.85%
XORTX Therapeutics
CPT111.361.02
+0.92%
Camden Property Trust
TMCI7.17N/A
N/A
Treace Medical Concepts
AGIO36.01-0.12
-0.33%
Agios Pharmaceuticals
ZENV1.51-0.05
-3.21%
Zenvia